Advertisement
Research Article Free access | 10.1172/JCI112292
Find articles by Merke, J. in: JCI | PubMed | Google Scholar
Find articles by Klaus, G. in: JCI | PubMed | Google Scholar
Find articles by Hügel, U. in: JCI | PubMed | Google Scholar
Find articles by Waldherr, R. in: JCI | PubMed | Google Scholar
Find articles by Ritz, E. in: JCI | PubMed | Google Scholar
Published January 1, 1986 - More info
1,25-dihydroxyvitamin D3 (1,25(OH)2D3) is known to stimulate osteoclastic bone resorption in vivo and whole organ bone culture systems in vitro. It has not been established whether 1,25(OH)2D3 acts directly on osteoclasts or whether its action on osteoclasts is mediated via other bone cells (e.g., osteoblasts) or recruitment of osteoclast precursor cells. Circulating monocytes have been characterized as osteoclast precursors. In the present study, vitamin D3-replete chicken on a calcium-deficient diet were studied. Circulating monocytes, whole bone cell preparations, and isolated osteoclasts (differential sedimentation) were examined for presence of 1,25(OH)2D3 receptors. Reversible, specific, and saturable binding of [3H]-1,25(OH)2D3 to a 3.5 S macromolecule was demonstrated in nuclear fractions of monocytes (maximal binding capacity, 48 fmol/mg protein; dissociation constant, 1.3 X 10(-10) M) and of whole bone cell preparations. 1,25(OH)2D3 receptors were not demonstrable in osteoclast preparations (70% pure; detection threshold, 2 fmol/mg protein). Data are consistent with indirect action of 1,25(OH)2D3 on osteoclastic bone resorption.
Click on an image below to see the page. View PDF of the complete article